Abstract
BackgroundBelimumab is a human monoclonal antibody that inhibits soluble B-Lymphocyte Stimulator and improves systemic lupus erythematosus (SLE) disease activity.ObjectivesThis study was initiated to evaluate the use and efficacy of belimumab...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have